Computer modeling of a potential agent against SARS-Cov-2 (COVID-19) protease

Arthur M Lesk1, Arun S Konagurthu2, Lloyd Allison2

  • 1Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania, USA.

Proteins
|July 15, 2020
PubMed
Summary

Researchers modeled modifications to a known ligand for the SARS-CoV-2 (COVID-19) protease. These modifications enhance covalent adduct formation and additional ligand-protein hydrogen bonds, aiding drug design.